CU Cancer Center’s First Assistant Director for Global Oncology

For Enrique Soto Pérez de Celis, treating cancer globally starts with treating cancer locally. It’s all part of Dr. Soto’s approach to treating and researching cancer on a global scale, which looks a little different than it does at similar programs at other cancer centers in the U.S.

Navigating Mental Health Around Cancer Diagnosis

Dr. Erin Baurle details the benefits of oncology counseling in helping patients with diagnosis disclosure and how to replace that familiar phrase of “let me know if you need anything” when offering to help a loved one with cancer.  

Studying the Power of Therapy Resistance

With support from a $3.3 million federal grant Virginia Borges, MD, and Traci Lyons, PhD, will investigate how a molecule they’ve been studying for a decade is able to promote resistance to therapies for a major type of breast cancer in the hopes of determining how to switch off the molecule’s harmful interference.

Exciting Updates for Bladder Cancer Treatment

At this years annual NCCN Conference in Orlando Dr. Flaig was excited to share the effectiveness of enfortumab vedotin, a new antibody drug conjugate that targets a particular or a bladder cancer cell and then delivers chemotherapy directly to that cell.